About this trial
As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Unilateral intraocular Retinoblastoma (RB)
Unilateral extraocular intraorbital (RB)
Bilateral intraocular (RB)
bilateral intraocular (RB) on one side and extraocular but intraorbital on the other side.
Disqualifiers
Externalized tumor mass
massive extension to optic nerve up to optical channeltumor
intracranial extension leptomeninges
cerebral parenchyma
Trial population
all children presenting at participating units who can be treated
Trial design
Cohort
Prospective
Treatments tested in this trial
OBSERVATIONAL
Other interventionWe will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.
Treatment groups
Trial outcomes
Primary outcomes
Number of cases with retinoblastoma in each participating hospital.
Evaluation of the number of cases registered .
Number of cases with stage 2 disease
Evaluation of the number of cases registered with stage 2 disease.
Feasibility of these therapeutic recommendations in an African setting
Evaluate the application of these therapeutic recommendations
Evaluating the treatment given.
Comparison of treatment given and recommended treatment.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.